INTS INTENSITY THERAPEUTICS, INC.
434
$5.28
$0.175
(3.43%)
| Watchers | 434 |
| 52-Wk Low | $2.01 |
| 52-Wk High | $11.44 |
| Market Cap | $69.93M |
| Volume | 9,281.00 |
| 52-Wk High | $11.44 |
| 52-Wk Low | $2.01 |
Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of DirectorsPR Newswire • 2 days ago
Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors PR...
Share to Feed
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in...
Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update PR...
Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024 Intensity Therapeutics to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Company generated approximately $2.8M of non-dilutive funding to extend cash runwayWESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage...
Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024 Intensity Therapeutics to Participate in the 36th Annual Roth Conference March 17 to 19, 2024 PR Newswire...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update Intensity Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update PR Newswire...
Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference Intensity Therapeutics to Present at the 2024 BIO CEO & Investor Conference PR Newswire SHELTON, Conn., Feb. 21, 2024...